4.7 Article

EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat diet

Journal

JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Volume 109, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2022.109094

Keywords

Key words; obesity; metabolic regulation; metabolomics; GTE intervention; EGCG; CAT

Funding

  1. United States Department of Agriculture-National Institute of Food and Agriculture [2019-67017-29259, 2014-67017-21761]
  2. Ohio State University (OSU) Center for Applied Plant Sciences
  3. OSU Ohio Agricultural Research and Development Center [USDA-HATCH OHO01452-MRF]
  4. Ohio State University Comprehensive Cancer Center
  5. National Institutes of Health [R35GM133510]
  6. NIH [P30 CA016058]
  7. NIFA [687115, 2014-67017-21761] Funding Source: Federal RePORTER

Ask authors/readers for more resources

This study investigated the unique contributions of green tea extract (GTE) and its catechin components to the regulation of gut microbial and host metabolic pathways. The findings suggest that GTE and its distinct bioactive components have differential benefits on gut microbial metabolism, central energy metabolism, and protection against metabolic dysfunction leading to obesity.
Green tea extract (GTE) alleviates obesity, in part, by modulating gut microbial composition and metabolism. However, direct evidence regarding the catechin-specific bioactivities that are responsible for these benefits remain unclear. The present study therefore investigated dietary supplementation of GTE, epigallocatechin gallate (EGCG), or ( + )-catechin (CAT) in male C57BL6/J mice that were fed a high-fat (HF) diet to establish the independent contributions of EGCG and CAT relative to GTE to restore microbial and host metabolism. We hypothesized that EGCG would regulate the gut microbial metabolome and host liver metabolome more similar to GTE than CAT to explain their previously observed differential effects on cardiometabolic health. To test this, we assessed metabolic and phenolic shifts in liver and fecal samples during dietary HF-induced obesity. Ten fecal metabolites and ten liver metabolites (VIP > 2) primarily contributed to the differences in the metabolome among different interventions. In fecal samples, nine metabolic pathways (e.g., tricarboxcylic acid cycle and tyrosine metabolism) were differentially altered between the GTE and CAT interventions, whereas three pathways differed between GTE and EGCG interventions, suggesting differential benefits of GTE and its distinctive bioactive components on gut microbial metabolism. Likewise, hepatic glycolysis / gluconeogenesis metabolic pathways were significantly altered between GTE and EGCG interventions, while only hepatic tyrosine metabolism was altered between CAT and GTE interventions. Thus, our findings support that purified catechins relative to GTE uniquely contribute to regulating host and microbial metabolic pathways such as central energy metabolism to protect against metabolic dysfunction leading to obesity. (C) 2022 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available